Top Purchases
The top purchases made by insiders recently. Returns and win rates reflect the insider’s prior buying activity.
Chief Medical Officer at Rezolute, Inc. ($RZLT)
The Chief Medical Officer purchased 2,500 shares at $4.38/share ($10.94K total) which increased their vested holdings by 17.4%. The current price is $4.31 (-1.5%). Their median purchase size is $18.08K and this is their 6th largest purchase out of 11 all time. (SEC Source)
Historic Returns
1m returns: +29.8% weighted | 78% win rate (7/9)
3m returns: +59.5% weighted | 78% win rate (7/9)
6m returns: +77.3% weighted | 78% win rate (7/9)
1y returns: +63.9% weighted | 89% win rate (8/9)
Note: 4 insiders have purchased shares in the past 30 days
Director at Marriott Vacations Worldwide Corporation ($VAC)
The Director purchased 750,000 shares at $67.83/share ($50.87M total) which increased their vested holdings by 22.8%. The current price is $68.37 (+0.8%). Their median purchase size is $6.71M and this is their 1st largest purchase out of 11 all time. (SEC Source)
Historic Returns
1m returns: +4.9% weighted | 70% win rate (7/10)
3m returns: +11.8% weighted | 90% win rate (9/10)
6m returns: +58.3% weighted | 100% win rate (10/10)
1y returns: +248.6% weighted | 90% win rate (9/10)
Director at Robinhood Markets, Inc. ($HOOD)
The Director purchased 26,500 shares at $74.19/share ($1.97M total) which increased their vested holdings by 6106.0%. The current price is $74.95 (+1.0%). Their median purchase size is $1.96M and this is their 1st largest purchase out of 2 all time. (SEC Source)
Historic Returns
1m returns: +31.6% weighted | 100% win rate (1/1)
3m returns: +0.1% weighted | 100% win rate (1/1)
6m returns: +58.3% weighted | 100% win rate (1/1)
1y returns: +219.8% weighted | 100% win rate (1/1)
Director at Third Coast Bancshares, Inc. ($TCBX)
The Director purchased 8,300 shares at $30.30/share ($251.49K total) which increased their vested holdings by 5.4%. The current price is $29.93 (-1.2%). Their median purchase size is $159.5K and this is their 1st largest purchase out of 2 all time. (SEC Source)
Historic Returns
1m returns: +13.4% weighted | 100% win rate (1/1)
3m returns: +37.5% weighted | 100% win rate (1/1)
6m returns: +4.4% weighted | 100% win rate (1/1)
1y returns: +41.5% weighted | 100% win rate (1/1)
Note: 2 insiders have purchased shares in the past 30 days
Director at Quanterix Corporation ($QTRX)
The Director purchased 210,000 shares at $5.40/share ($1.13M total) which increased their vested holdings by 14.0%. The current price is $5.06 (-6.3%). Their median purchase size is $1.05M and this is their 3rd largest purchase out of 6 all time. (SEC Source)
Historic Returns
1m returns: +15.0% weighted | 60% win rate (3/5)
3m returns: +30.7% weighted | 80% win rate (4/5)
6m returns: +37.2% weighted | 80% win rate (4/5)
1y returns: +102.9% weighted | 100% win rate (4/4)
Buying the dip (stock was down -31.62% in the 3 months prior to the purchase)
Co-Founder at MDB Capital Holdings, LLC ($MDBH)
The Co-Founder purchased 2,632 shares at $3.93/share ($10.33K total) which increased their vested holdings by 1.9%. The current price is $3.77 (-4.0%). Their median purchase size is $38.33K and this is their 9th largest purchase out of 13 all time. (SEC Source)
Historic Returns
1m returns: +15.7% weighted | 82% win rate (9/11)
3m returns: +60.9% weighted | 100% win rate (9/9)
6m returns: +61.6% weighted | 100% win rate (9/9)
1y returns: +216.3% weighted | 100% win rate (9/9)
Buying the dip (stock was down -45.05% in the 3 months prior to the purchase)
Director at Core Scientific, Inc. ($CORZ)
The Director purchased 110,000 shares at $10.87/share ($1.2M total) which increased their vested holdings by 30.1%. The current price is $10.69 (-1.6%). Their median purchase size is $307.71K and this is their 1st largest purchase out of 7 all time. (SEC Source)
Historic Returns
1m returns: +3.5% weighted | 75% win rate (3/4)
3m returns: +191.8% weighted | 100% win rate (4/4)
6m returns: +234.5% weighted | 100% win rate (4/4)
1y returns: +309.3% weighted | 100% win rate (4/4)
Top Sales
The top sales made by insiders yesterday. Remember, returns and win rates are calculated using the previous sell trades by the insider. For sell transactions, “win rate” is the percent of profitable trades. If the “win rate” is low, that means the stock typically falls after the insider sells.
Chief Marketing Officer at Ibotta, Inc. ($IBTA)
The Chief Marketing Officer sold 85,289 shares at $43.09/share ($3.67M total) which decreased their vested holdings by 28.6%. The current price is $41.34 (-4.1%). Their median sale size is $939.09K and this is their 1st largest sale out of 10 all time. (SEC Source)
Historic Returns
1m returns: +8.2% weighted | 88% win rate (7/8)
3m returns: +27.9% weighted | 88% win rate (7/8)
6m returns: +24.9% weighted | 100% win rate (3/3)
1y returns: +31.8% weighted | 100% win rate (1/1)
Note: 9 insiders have sold shares in the past 30 days
10% Owner at Aveanna Healthcare Holdings Inc. ($AVAH)
The 10% Owner sold 750,000 shares at $5.20/share ($3.9M total) which decreased their vested holdings by 1.4%. The current price is $5.08 (-2.3%). Their median sale size is $1.87M and this is their 2nd largest sale out of 8 all time. (SEC Source)
Historic Returns
1m returns: +1.7% weighted | 100% win rate (3/3)
3m returns: N/A
6m returns: N/A
1y returns: N/A
Selling the rip (stock was up 35.83% in the 3 months prior to the sale)
Note: 10 insiders have sold shares in the past 30 days
Chief Medical Officer at Protagonist Therapeutics, Inc. ($PTGX)
The Chief Medical Officer sold 20,000 shares at $56.27/share ($1.13M total) which decreased their vested holdings by 11.1%. The current price is $55.34 (-1.7%). Their median sale size is $724.8K and this is their 3rd largest sale out of 6 all time. (SEC Source)
Historic Returns
1m returns: +15.2% weighted | 100% win rate (2/2)
3m returns: +3.8% weighted | 100% win rate (1/1)
6m returns: -1.3% weighted | 0% win rate (0/1)
1y returns: N/A
Selling the rip (stock was up 28.79% in the month prior to the sale)
SVP, CFO, Chief Acct. Officer at Emerson Radio Corp. ($MSN)
The SVP, CFO, Chief Acct. Officer sold 750 shares at $485.54/share ($364.15K total) which decreased their vested holdings by 4.0%. The current price is $0.42 (-99.9%). Their median sale size is $182.16K and this is their 1st largest sale out of 2 all time. (SEC Source)
Historic Returns
1m returns: +0.2% weighted | 100% win rate (1/1)
3m returns: +17.0% weighted | 100% win rate (1/1)
6m returns: +11.3% weighted | 100% win rate (1/1)
1y returns: +25.0% weighted | 100% win rate (1/1)
Note: 1 other insider also sold shares
VP and Controller at Emerson Radio Corp. ($MSN)
The VP and Controller sold 447 shares at $485.37/share ($216.96K total) which decreased their vested holdings by 8.1%. The current price is $0.42 (-99.9%). Their median sale size is $108.57K and this is their 1st largest sale out of 2 all time. (SEC Source)
Historic Returns
1m returns: +0.2% weighted | 100% win rate (1/1)
3m returns: +17.0% weighted | 100% win rate (1/1)
6m returns: +11.3% weighted | 100% win rate (1/1)
1y returns: +25.0% weighted | 100% win rate (1/1)
Note: 1 other insider also sold shares
SVP, General Counsel at Abeona Therapeutics Inc. ($ABEO)
The SVP, General Counsel sold 10,470 shares at $6.76/share ($70.78K total) which decreased their vested holdings by 2.7%. The current price is $6.74 (-0.3%). Their median sale size is $26.69K and this is their 1st largest sale out of 5 all time. (SEC Source)
Historic Returns
1m returns: +8.1% weighted | 75% win rate (3/4)
3m returns: +66.1% weighted | 100% win rate (4/4)
6m returns: +70.3% weighted | 100% win rate (4/4)
1y returns: +79.6% weighted | 100% win rate (4/4)
Selling the rip (stock was up 57.48% in the year before the sale)
Director at The Oncology Institute, Inc. ($TOI)
The Director sold 1,976,137 shares at $2.87/share ($5.67M total) which decreased their vested holdings by 76.6%. The current price is $2.79 (-2.8%). Their median sale size is $1.95M and this is their 1st largest sale out of 3 all time. (SEC Source)
Historic Returns
1m returns: +28.0% weighted | 100% win rate (2/2)
3m returns: +11.9% weighted | 100% win rate (2/2)
6m returns: +68.8% weighted | 100% win rate (2/2)
1y returns: +91.5% weighted | 100% win rate (2/2)
Selling the rip (stock was up 323.69% in the 3 months before the sale)
Chief People Officer at Ibotta, Inc. ($IBTA)
The Chief People Officer sold 1,243 shares at $49.44/share ($61.45K total) which decreased their vested holdings by 2.2%. The current price is $48.16 (-2.6%). Their median sale size is $407.99K and this is their 5th largest sale out of 7 all time. (SEC Source)
Historic Returns
1m returns: +0.5% weighted | 50% win rate (3/6)
3m returns: +43.0% weighted | 83% win rate (5/6)
6m returns: +24.4% weighted | 100% win rate (3/3)
1y returns: +25.4% weighted | 100% win rate (1/1)
Selling the rip (stock was up 37.60% in the 3 months before the sale)
Chief Product Officer at Beta Bionics, Inc. ($BBNX)
The Chief Product Officer sold 1,115 shares at $17.89/share ($19.95K total) which decreased their vested holdings by 1.2%. The current price is $19.45 (+8.7%). Their median sale size is $10.08K and this is their 1st largest sale out of 2 all time. (SEC Source)
Historic Returns
1m returns: +19.9% weighted | 100% win rate (1/1)
3m returns: +49.3% weighted | 100% win rate (1/1)
6m returns: N/A
1y returns: N/A
Selling the rip (stock was up 34.79% in the week before the sale)
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
